Find in our current newsletter the latest developments on Swiss and international corporate tax, indirect tax and transfer pricing topics.
Find here an overview of selected Corporate Tax developments during Q1 2024. Stay ahead with our insightful Corporate Tax updates.
The national implementation of the OECD minimum tax continues to progress. The following countries have implemented the Pillar Two minimum tax rules as of January 1, 2024:
Switzerland
Germany
Principality of Liechtenstein
Italy
For further information, please see our blog post and our International Tax News.
You may find further information in our blog post.
US President Joe Biden presented the draft budget for 2025 in March 2024. Among other things, the draft includes various tax increases. For example, households with assets of over USD 100 million are to pay a minimum tax of 25%. Corporate taxes are to be raised to 28% and taxes on foreign income of international corporations are to be increased to 21%.
Until recently, there was no corporate income tax in Bermuda. In light of the OECD minimum taxation, Bermuda will now introduce a 15% corporate income tax for group companies of multinational groups from 2025. You can find more information here.
Effective January 1, 2024, Singapore will introduce various changes to the local participation exemption on the disposal of foreign assets. For more information, see our Tax Bulletin.
For ongoing updates from the international tax world, we recommend our international Tax News, which you can access here.
The Swiss Federal Tax Administration (SFTA) has published the circular letters on the tax-recognized interest rates for 2024 for advances or loans in Swiss francs and foreign currencies. These letters can be found under this link.
Further information can be found in our blog.
The Lucerne tax administration has published a newsletter on the practice of converting share capital into a foreign currency. The newsletter can be found under this link.
At its meeting on January 31, 2024, the Federal Council decided on the legal basis for the innovative fund product L-QIF (Limited Qualified Investor Fund). The communication can be found under this link.
At its meeting on March 27, 2024, the Federal Council decided to leave the interest rates for outstanding Covid-19 loans unchanged as of March 31, 2024. For loans up to CHF 500’000, 1.5 percent will continue to be payable and for loans over CHF 500’000, 2 percent will continue to be payable. The message can be found under this link.
The Federal Council has adopted the message on the popular initiative “For individual taxation independent of marital status (tax justice initiative)” and the indirect counter-proposal (Federal Law on Individual Taxation). The message can be found under this link.
Circular letter No. 26 on self-employment has been formally updated. The changes particularly affect the deferral provision pursuant to Art. 18b DBG and the taxation provision pursuant to Art. 37b DBG in connection with the Federal Supreme Court decision (2C_255/2019 of March 9, 2020). The circular letter can be found here.
On March 1, 2024, the Federal Council created the national legal basis for the taxation of teleworking by cross-border commuters by adopting the legislative message. This will enable cross-border commuters to be taxed even if they perform teleworking abroad. The message can be found here.
The Zurich cantonal tax administration has published a practical note on the cost-plus method and several adapted information sheets on withholding tax in the Zurich tax book. The published information sheets and the practical note can be found here.
The draft for a partial revision of the tax law and the economic development law has been released for consultation. The aim of the adjustment of the tax law is to ensure that Graubünden municipalities receive an appropriate share of possible additional income from the OECD minimum tax. The economic development law is intended to create a new funding instrument (so-called qualifying tax credit) to strengthen the attractiveness and competitiveness of the location. You can find more information on the revisions here.
At the end of the year 2023, the residents of the Canton of Schaffhausen have approved a partial revision of the cantonal law on direct taxes related to the OECD project on the taxation of large corporate groups. Coming into effect per January 1, 2024, respectively per January 1, 2025, the Cantonal tax law provides the following consequences for the taxation of companies:
From January 1, 2024, the Schaffhausen tax law will introduce multi-tiered tax scales for corporate income tax. The applicable cantonal tax rate is determined by the scale into which the taxable profit is classified. Scale 1 includes all taxable profits up to CHF 5 million. Scale 2 all taxable profits from CHF 5 million and up to CHF 15 million. Scale 3 ultimately includes all taxable profits over CHF 15 million.
Enclosed you will find a selection of the Swiss Federal Court (SFC) and cantonal court decisions, that may be of interest to you:
SFC dated 7 December 2023: Permissibility of Levying Real Estate Transfer Tax in the Event of a Fund Management Change
SFC dated 5 January 2024: Tax deductibility of a share purchase of the renewal fund of a condominium unit
SFC dated 2 November 2023: Intercantonal tax allocation for inheritance tax purposes and in particular the application of two different methods applied
SFC dated 7 September 2023: Exemption from stamp duty requires the elimination of existing losses. This contradicts the decision of the Swiss Federal Administrative Court of 29 November 2021. The SFAC had decided that in the case of a qualified reorganisation, the stamp duty exemption under Art. 6 I k StG and Art. 12 StG does not require existing losses to be offset/eliminated.
We hope that this newsletter contains some topics of interest to you. If you have any questions, please do not hesitate to contact us. For ongoing updates from the world of tax, we also recommend our personalized newsletter, for which you can register using this link.
Find here an overview of the latest transfer pricing topics.
On 19th February 2024, the OECD/G20 Inclusive Framework (“IF”) published a report on setting the remuneration of baseline marketing and distribution functions within multinational groups – so called Amount B of Pillar 1 of BEPS 2.0. The new guidance outlines how to determine arm’s length profitability levels for one of the most commonly applied intragroup business activities: distribution of products by entities operating under a limited risk profile, either through a buy-sell model or utilizing group companies acting as sales agents / commissionaires.
Please see our blog post here.
The Swiss tax authorities, namely the SSK (Schweizerische Steuerkonferenz) and the SFTA (Swiss Federal Tax Authorities), have issued a comprehensive article on transfer pricing.
This article is the first extensive guidance from Swiss tax authorities on the intricacies of transfer pricing. The article, published on January 23, 2024, delves into a number of aspects of transfer pricing: confirming the legislative basis for transfer pricing in Switzerland, the interpretation of the arm’s length principle in relation to comparability analyses, the selection of transfer pricing methods, and providing transfer pricing guidance on specific issues relating to intangible property, intercompany services and financing transactions.
In addition, the topic of maintaining appropriate transfer pricing documentation is addressed where reference is made to the OECD’s three-tier approach consisting of Master File, Local File and Country-by-Country Reporting. In this context, the article notes that, while there is no legal requirement to prepare Master and Local Files in Switzerland, taxpayers have an obligation to cooperate and are, therefore, required to provide evidence for the arm’s length character of their transfer prices upon request by the authorities. Our practical experience shows that this is best achieved by presenting an OECD-compliant documentation package consisting of Master and Local Files.
The tax authorities also reiterate the option for taxpayers to discuss and agree their transfer pricing in advance, which we know is a clear advantage of the Swiss tax regime compared to the tax regimes of most other countries. The guidance on rulings includes a recommendation that applications are filed simultaneously at both the Federal and Cantonal Tax Authorities and notes that ruling requests must be filed with appropriate supporting documentation (for example a transfer pricing study). Both are notable because whilst we often did this in the past, we did not always do it. It shall further be noted that transfer pricing rulings are typically subject to the automatic ruling exchange due to their cross-border nature.
See also our article and practical recommendations in this regard from our colleague Robert Fischer.
Furthermore, the SFTA has published a new website containing a list with frequently asked questions in various areas. The list may be expanded in the future by further topics. Please see also our blog post here in relation to the Cost+ method, withholding tax in connection with primary, countervailing and secondary adjustments, tax consequences of the Altera v. Commissioner decision of the US Tax Court of 7 June 2019 for Swiss taxpayers and intercompany loan arrangements.
This website is currently available in German and French and can be found here.
Australia is moving ahead with introducing public country-by-country (CbC) reporting requirements, following the EU public CbC Reporting Directive that established a common framework for such disclosures in the EU. Australia has recently released revised draft legislation that reflects stakeholder feedback and aligns more closely with the EU public CbC regime.
Under the revised draft legislation, CbC reporting parent entities with annual global income of A$1 billion or more and A$10 million or more of Australian-sourced income will be required to certain qualitative and quantitative tax information, disaggregated for Australia and 41 specified jurisdictions.
The specified jurisdictions list includes Switzerland. Although the “specified jurisdictions” are based on the current Exposure Draft and jurisdictions may be added or removed by legislative instrument, if the draft legislation is enacted with the current list, multinationals groups subject to Australian public CbC regime will have to publish information related to Switzerland.
The revised draft legislation allows for aggregation of financial and tax information for other jurisdictions, unless voluntarily disclosed on a CbC basis. It also imposes penalties for failure to publish the required information on time, ranging from A$6,260 to A$782,500, depending on the duration of the delay and the frequency of the offense.
Under the current draft, for a December reporting period, the year ending 31 December 2025 would be the first year subject to Australian public CBC reporting, with reporting due by 31 December 2026.
Please find the link to our PwC Tax Alert here.
Italy has introduced a new act on the TP compliance requirements. One of the key differences compared to the previous rules is the new shorter deadline for submission of the TP documentation, which now is 9 months after the fiscal year-end for the FY 2023 documentation for the taxpayers with fiscal year-end on 31st December 2022. This means that the deadline for the tax return, and thus to have the TP documentation prepared, digitally signed and timestamped, would be 30th September 2024 (instead of 30th November).
Here is a short article by PwC for your reference.
Find here an overview of selected Indirect Tax developments during Q1 2024. The provided overview includes development on Swiss and EU level as well as pharma regulatory insights. Stay ahead with our insightful Indirect Tax updates.
The free trade agreement between the EU and New Zealand, which was signed on 9 July 2023, will enter into force on 1 May 2024. Bilateral trade in goods between the EU and New Zealand has steadily increased in recent years and reached a volume of almost € 9.1 billion in 2022, making the EU New Zealand's third largest trading partner.
The EU expects this agreement to result in annual savings of approximately € 140 million in customs duties for EU companies, a potential growth of up to 30% in bilateral trade, an increase in annual EU exports by up to € 4.5 billion, and up to 80% more EU investment in New Zealand. Additionally, this free trade agreement is the first to fully encompass the EU's approach to trade and sustainable development.
The European Commission has adopted a new regulation that will introduce binding valuation information (BVI) decisions for traders and customs authorities in the EU. BVI decisions will provide clarity and consistency on how to determine the customs value of imported or exported goods, which affects the amount of customs duties and other charges payable at the EU border. BVI decisions are valid for three years and binding for both the holder of the decision and the customs authorities throughout the EU.
To gain the binding valuation information, it should be requested by the economic operator. Within seven days at the latest, the customs authorities decide on the binding customs valuation information, providing the appropriate method of customs valuation or criteria, and the application thereof, to be used for determining the customs value of goods under particular circumstances. The BVI decision must be indicated in the customs declaration with the corresponding reference number.
Furthermore, the regulation updates the existing rules on binding tariff information (BTI) and binding origin information (BOI), which define the classification and origin of goods for customs purposes.
The regulation will only apply from 1 December 2027, when the electronic system for managing BVI, BTI and BOI decisions is expected to be ready.
EU Parliament adopted its position on the proposals for the significant reform of the EU Customs Code on 13 March 2024. The package contains three separate legal acts:
Main regulation that establishes the EU Customs Code and the EU Customs Authority,
Council regulation on simplified tariff treatment for the distance sales and elimination of the customs duty relief threshold, and
Council directive on a special scheme for distance sales of goods imported from third countries and import VAT.
The reform aims to change the way customs authorities operate, cooperate with traders, and manage goods that people order online. Therefore, this reform intends to impact the three key areas:
E-Commerce: Platforms will be obliged to submit data on goods shipped to the EU within one day, aiming to ensure that goods comply with the EU standards and legal norms, and to reduce the undervaluation of imported goods.
Trusted partners: Companies can undergo preliminary checks and controls to obtain a trusted trader status. Such companies can operate with a minimum of checks and paperwork, making customs procedures easier and faster.
New digital solutions: The new EU DataHub will be the main IT system for all European customs authorities and simplify the communication and submission of information for businesses.
The position will be followed up by the new Parliament after the European election in June. The gradual implementation of the reform is expected to take place from 2028 to 2038 (not defined yet).
In the EU, we are currently witnessing significant developments in the ESG (Environmental, Social, Governance) tax landscape. New levies are constantly being introduced, both small and large, which require our attention. These include among other plastic packaging taxes, sugar taxes, and the extended producer responsibility. All of these topics fall within the realm of ESG and are becoming increasingly important.
Businesses will be required to pay the levy in spring 2025.
On 17 August 2023, the European Commission adopted the Implementing Regulation for the transitional period relating to the Carbon Border Adjustment Mechanism (CBAM). The approved Implementing Regulation and accompanying guidance:
Confirms the reporting obligations for the CBAM transitional period, which commenced on 1 October 2023. Furthermore, it confirms that the CBAM reporting requirements and methodology will provide some flexibility when it comes to the values used to calculate embedded emissions on imports during the transitional phase.
Provides further guidance on the calculation of embedded emissions. Critically, the use of ‘default values’ are not limited for the first three quarterly CBAM reports (i.e., until 31 July 2024). However, after this date, default values may only be used for up to 20% of embedded emissions for complex goods and would qualify as “estimation”.
Note that first CBAM report (covering the fourth quarter of 2023) was initially due by 31st January 2024 but the European Commission extended this deadline to 31st March 2024.
The CBAM was announced as part of the European Commission’s ‘Fit for 55’ package. This initiative aims to reduce net greenhouse gas emissions by at least 55% by 2030, compared to 1990 levels. The CBAM is designed to contribute to this objective and prevent from a carbon leakage. Practically speaking, the CBAM will be a tax on the importation of carbon-intensive products from outside the European Union. In summary, the CBAM will likely affect businesses in three ways:
It will increase the risk of non-compliance if affected businesses aren’t familiar with the, admittedly rather complex, process.
It will increase the time (and associated costs) required to collect and to process data from suppliers.
It will increase costs through the additional carbon price to be paid – as of 2026.
It will increase reporting / administrative obligations for businesses.
Consequently, if you are active in the cement, iron, steel, aluminium, fertiliser, electricity or hydrogen industries (or in the value chain of these products), you should begin to assess how CBAM will impact you. Whilst you may not have a direct reporting obligation, you should expect to receive information requests from those impacted.
On 7 December 2023, the PEM Joint Committee adopted the new and modernized rules of origin that aim to increase trade between the European Union and neighboring countries in the PEM region. The rules of origin will be implemented as of 1 January 2025 and will aim to modernise all preferential trade agreements among the 24 PEM trading partners by making the relevant rules of origin in those agreements more flexible and business-friendly.
The PEM Joint Committee also agreed to develop the use of electronic certification of origin in the view of further simplification of customs formalities.
Effective from 1 January 2024, a new version of the EU Combined Nomenclature takes effect. Although the tariff changes are relatively minor, businesses must ensure their customs declarations accurately reflect any updates or new CN codes to avoid errors, fines and customs delays.
On 8 December 2022 the European (EU) Commission released its “VAT in the Digital Age (ViDA)” package, which is a set of proposals for new measures aiming to tackle the challenges of the digitization of the economy and to create a more resilient system against VAT fraud.
The proposal deals with following main topics:
The ViDA initiative is an ambitious package that will result in significant changes and will have a major impact on systems and processes for a large number of businesses. However, the proposals are yet to go through the EU’s legislative process and will require the unanimous approval of all EU Member States as well as implementation in national legislations. Therefore, it remains to be seen whether the implementation of all proposed measures will be possible within the planned timeframe.
September 2026 - All businesses to be able to receive e-invoices
September 2026 - Large and mid-size businesses obliged to issue e-invoices
September 2027 - SMEs (including VSEs) obliged to issue e-invoices
The above timeline is subject to the legislative process and may still change.
Pharmaceutical companies selling drugs listed on the Speciality List (SL) in Switzerland have the opportunity to gain a valuable VAT benefit that could significantly enhance their financial standing. The reason for this opportunity is a recent shift in the approach of health and/or disability insurers regarding the rebates required under Swiss law (KVV Article 71a).
Previously, pharmaceutical companies had to grant rebates for Specialty List (SL) medicines under KVV Art. 71a if those drugs had been used in special cases, the price had to be below the price listed on the SL with no further stipulation in the law.
Non-SL drugs (which typically are not reimbursed by the health insurance) are reimbursed in special cases under KVV Art 71b, the prices in those cases were subject to negotiation between the health insurance and the pharmaceutical company. Rebates in those cases were not obligatory, but often agreed upon in the negotiations.
The partial revision of the KVV which went into force on 1 January 2024 now requires pharmaceutical companies to grant a set percentage of rebate on drugs reimbursed in special cases, regardless of whether those Drugs are listed in the SL or not, the same rebates apply for both SL and non-SL drugs.
Until recently, these rebates were usually issued with VAT on the credit notes, but recently, many insurers have requested the credit notes to be issued without VAT, to avoid any VAT risk on their side.
This change implies that pharmaceutical companies may have inadvertently VAT on these rebates in the past that can be claimed back. The good news is that such overpaid VAT amounts can be reclaimed from the Swiss VAT authorities, provided that a VAT ruling confirming this option is in place. We've been instrumental in assisting numerous pharmaceutical clients in securing these rulings, enabling them to recoup substantial VAT sums spanning the past five years.
A comprehensive exploration of the KVV Art 71a to c revision from a tax perspective can be found in our recent blog post.
Our Swiss Pharma Regulatory and Indirect Tax experts are looking forward to discussing VAT refund opportunities together with you.
If you are a pharmaceutical company based in Switzerland or outside the EU, you may be wondering how the proposed EU Pharma Legislation Reform will affect your operations in the European market. This reform aims to modernise and harmonise the rules for medicinal products for human use, with implications for research, manufacturing, distribution and storage activities. In our latest blog post, we explore the key aspects of the reform, such as:
The new obligations for wholesale distribution authorisation holders, including stricter sourcing rules, authenticity verification and continuous supply guarantees
The introduction of 'brokers' as intermediaries in the sale or purchase of medicinal products, and the requirements they must meet
The environmental sustainability and crisis management measures to protect public health and the environment
The challenges for non-EU companies, especially those holding a Swiss wholesale authorisation, in light of the German court case that restricts their access to the EU market
The timelines and deadlines for the adoption and implementation of the reform
We also share our insights and recommendations on how to proactively mitigate the risks and ensure compliance with the current and future regulatory landscape. We have extensive experience in assisting pharma companies with tailored and integrated solutions for a resilient supply chain from a tax and regulatory perspective.
Learn more about the EU Pharma Legislation Reform and how it will impact your business. Read our full blog post here and contact us for further guidance and support.
Artificial intelligence (AI) will fundamentally reshape how companies operate in the Life Sciences industry. Hot topics include the governance and ethical concerns in the wake of the rapid rise of AI and Machine Learning (ML) in the mainstream. Balancing innovation with ethical considerations and sustainable practices is an ongoing challenge that demands harmonious integration of regulatory frameworks and industry best practices.
How AI can benefit pharmaceutical companies
Solving important problems for the pharma regulatory function
The regulatory function faces an array of tasks in their day-to-day activities, from managing complex data and technical documents to navigating evolving regulations and help address patient needs. AI offers the potential to lighten this load, freeing up resources for the team to concentrate on tasks that require human creativity and insight. Potential use cases for generative AI in the Pharma regulatory function include:
Regulatory Intelligence: AI could streamline the monitoring and interpretation of regulatory changes, providing timely alerts and decision support for compliance.
Document Management and Dossier Preparation: AI could enhance efficiency in regulatory document creation and dossier preparation by automating data analysis and ensuring compliance.
Regulatory Submissions and Interactions: AI facilitates quicker and predictive responses to health authority inquiries, improving the efficiency of regulatory submissions and interactions.
Compliance and Pharmacovigilance: AI could proactively monitor drug safety and compliance, predicting and addressing potential issues through analysis of diverse data sources.
Conflicts and Problems:
Proposed Solutions:
Conclusion:
The convergence of AI and regulatory compliance presents immense opportunities for the Pharma Regulatory Function. While challenges persist, proactive strategies and collaborative efforts can ensure responsible AI integration. PwC's tailored accelerator program (AI Acceleration Program) stands ready to guide Life Sciences companies in unlocking AI's transformative potential while navigating regulatory complexities.
Robert Fischer
Director, Transfer Pricing & Value Chain Transformation, PwC Switzerland
PwC research reveals the critical role of tax in business strategy and highlights potential actions for realising its full potential.
Our survey reveals how tax functions adapt to regulatory, sustainability, and technological changes.
In the circular letters dated 27 January and 28 January 2025, the SFTA published the safe harbour interest rates applicable for 2025.
The OECD released new publications on Pillar 2 compliance. This blog post focuses on the GIR aspects and Swiss Pillar 2 compliance considerations.